Enterprise Value to EBITDA Multiple ratio Analysis of Tango Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-7.99
Period Ending - Dec-22
Very Poor EV to EBITDA
-6.82
Growth
-17.19 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-7.34
EV to EBITDA Analysis of Tango Therapeutics Inc
| EV to EBITDA Ratio of TNGX has fallen by -17.19 % Compared to previous Financial Year. |
| EV to EBITDA Ratio with value of -0.131 was highest in Year Dec-21 in last Five Years. |
| EV to EBITDA Ratio with value of -6720.40 was lowest in Year Dec-20 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -7.99 is Greater than Average EV to EBITDA of -1347.86 in last five years. |
Other EV to EBITDA Related Info of TNGX that may interest you.
Tango Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| TNGX | 8.93 | 8.39 | 6.44 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Tango Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| EV to EBITDA | -7.99 | -6.82 | -0.131 | -6720.40 | -3.95 |
| Change | -17.19 % | -5104.10 % | 100.00 % | -170026.91 % |
FY Chart of Enterprise Value to EBITDA Multiple of Tango Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)